These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21930188)

  • 1. Wnt/β-catenin signalling in adrenal physiology and tumour development.
    Berthon A; Martinez A; Bertherat J; Val P
    Mol Cell Endocrinol; 2012 Mar; 351(1):87-95. PubMed ID: 21930188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wnt/beta-catenin pathway in adrenocortical development and cancer.
    El Wakil A; Lalli E
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):32-7. PubMed ID: 21094679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
    Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells.
    Rider V; Isuzugawa K; Twarog M; Jones S; Cameron B; Imakawa K; Fang J
    J Endocrinol; 2006 Dec; 191(3):537-48. PubMed ID: 17170212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of beta-catenin localization by immunohistochemistry.
    Barker N; van den Born M
    Methods Mol Biol; 2008; 468():91-8. PubMed ID: 19099248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
    Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
    EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention.
    Krieghoff E; Behrens J; Mayr B
    J Cell Sci; 2006 Apr; 119(Pt 7):1453-63. PubMed ID: 16554443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleo-cytoplasmic shuttling of APC can maximize β-catenin/TCF concentration.
    Schmitz Y; Wolkenhauer O; Rateitschak K
    J Theor Biol; 2011 Jun; 279(1):132-42. PubMed ID: 21439299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
    Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
    J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
    Schmitz Y; Rateitschak K; Wolkenhauer O
    Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
    Fu X; Li L; Peng Y
    J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
    Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
    J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
    Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
    J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the Wnt/β-catenin/TCF response elements in the human versican promoter.
    Rahmani M; Carthy JM; McManus BM
    Methods Mol Biol; 2012; 836():35-52. PubMed ID: 22252626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.